Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 6/20 | 0.54 |
| ▸ | NPC1 | O15118 | 4/20 | 0.54 |
| ▸ | HPGD | P15428 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29895062 | 1.00 | MAPT (0.59) | MAPTSMN1; SMN2NPSR1RAB9ANPC1 | |
| SCHEMBL15725683 | 0.94 | MAPT (0.70) | MAPTSMN1; SMN2NPSR1RAB9ANPC1 | |
| SCHEMBL711456 | 0.94 | MAPT (0.70) | MAPTSMN1; SMN2NPSR1RAB9ANPC1 | |
| SCHEMBL15723247 | 0.94 | MAPT (0.70) | MAPTSMN1; SMN2NPSR1RAB9ANPC1 | |
| SCHEMBL15723250 | 0.94 | MAPT (0.70) | MAPTSMN1; SMN2NPSR1RAB9ANPC1 | |
| SCHEMBL13320283 | 0.92 | SMN1; SMN2 (0.52) | MAPTSMN1; SMN2NPSR1RAB9ANPC1 | |
| SCHEMBL8191180 | 0.91 | MAPT (0.55) | MAPTSMN1; SMN2NPSR1RAB9ANPC1 | |
| SCHEMBL28614565 | 0.91 | MAPT (0.50) | MAPTSMN1; SMN2NPSR1RAB9ANPC1 | |
| SCHEMBL8639791 | 0.90 | MAPT (0.77) | MAPTSMN1; SMN2NPSR1RAB9ANPC1 | |
| SCHEMBL13320281 | 0.88 | MAPT (0.61) | MAPTSMN1; SMN2NPSR1RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110665544-A | Preparation method and application of organic semiconductor photocatalyst | 广州市骏辉环保科技有限公司 | 2020-01-10 | — | — | CN | claimed |
| CN-119462465-A | Method for preparing tertiary benzylamine by photocatalysis | 南昌大学 | 2025-02-18 | — | — | CN | disclosed |
| US-20250014774-A1 | PEROVSKITE-ORGANIC CHROMOPHORE BASED X-RAY IMAGINING SCINTILLATOR | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2025-01-09 | — | — | US | disclosed |
| EP-4267588-A1 | MECHANOCHROMIC AND MECHANOFLUOROCHROMIC COMPOUND, COMPOSITION, AND FIDUCIARY DOCUMENT USING SAME | Oberthur Fiduciaire SAS (FR) | 2023-11-01 | — | — | EP | disclosed |
| US-11754498-B2 | Single AIEgen for multiple tasks: imaging of dual organelles and evaluation of cell viability | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-09-12 | — | — | US | disclosed |
| WO-2023073662-A1 | PEROVSKITE-ORGANIC CHROMOPHORE BASED X-RAY IMAGINING SCINTILLATOR | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2023-05-04 | — | — | WO | disclosed |
| CN-113307818-B | Fluorescent probe with fluorescence imaging and photodynamic functions, nano preparation thereof and preparation method | 复旦大学 | 2022-09-02 | — | — | CN | disclosed |
| WO-2022135913-A1 | MECHANOCHROMIC AND MECHANOFLUOROCHROMIC COMPOUND, COMPOSITION, AND FIDUCIARY DOCUMENT USING SAME | OBERTHUR FIDUCIAIRE SAS (FR) | 2022-06-30 | — | — | WO | disclosed |
| CN-113307818-A | Fluorescent probe with fluorescence imaging and photodynamic functions, nano preparation thereof and preparation method | 复旦大学 | 2021-08-27 | — | — | CN | disclosed |
| US-20210109024-A1 | Single AIEgen for Multiple Tasks: Imaging of Dual Organelles and Evaluation of Cell Viability | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2021-04-15 | — | — | US | disclosed |
| EP-0731625-B1 | Organic electroluminescent devices with high thermal stability | EASTMAN KODAK CO (US) | 2003-04-16 | — | — | EP | disclosed |
| EP-0731625-A2 | Organic electroluminescent devices with high thermal stability | EASTMAN KODAK COMPANY (US) | 1996-09-11 | — | — | EP | disclosed |
| US-5554450-A | Organic electroluminescent devices with high thermal stability | EASTMAN KODAK COMPANY (US) | 1996-09-10 | — | — | US | disclosed |
| US-5080989-A | Polycarbonate, solvent resistance | EASTMAN KODAK COMPANY (US) | 1992-01-14 | — | — | US | disclosed |
| US-4431722-A | POLYCYCLIC QUINONE PIGMENT DISPERSED IN A RESIN BINDER AS CHARGE GENERATING LAYER; ANTIFOGGING AGENTS | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-02-14 | — | — | US | disclosed |
| US-4361636-A | COLORANT | EASTMAN KODAK COMPANY (US) | 1982-11-30 | — | — | US | disclosed |
| US-4349617-A | Function separated type electrophotographic light-sensitive members and process for production thereof | FUJI PHOTO FILM CO., LTD. (JP) | 1982-09-14 | — | — | US | disclosed |
| US-4322487-A | Composite electrically photosensitive particles for electrophoretic migration imaging process | EASTMAN KODAK COMPANY (US) | 1982-03-30 | — | — | US | disclosed |
| US-4018607-A | Crystalline organic pigment sensitizers for photoconductive layers | EASTMAN KODAK COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
| US-4018606-A | Organic azo pigment sensitizers for photoconductive layers | EASTMAN KODAK COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210109024-A1 | Single AIEgen for Multiple Tasks: Imaging of Dual Organelles and Evaluation of Cell Viability | ACAA2, ACAT1, HAGH | MAPT 2024/4885SMN1; SMN2 1972/4885NPSR1 4412/4885 |
| US-11754498-B2 | Single AIEgen for multiple tasks: imaging of dual organelles and evaluation of cell viability | ACAA2, ACAT1, HAGH | MAPT 2024/4885SMN1; SMN2 1972/4885NPSR1 4412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.